Business

Astera Labs Announces Conference Call to Review Fourth Quarter 2024 Financial Results By Investing.com

Astera Labs Announces Conference Call to Review Fourth Quarter 2024 Financial Results By Investing.com

SANTA CLARA, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) — Astera Labs, Inc. (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced that it will release its financial results for the fourth quarter 2024 after the close of market on  Monday, Feb. 10, 2025. Astera Labs will host a corresponding conference call at  1:30 p.m. Pacific Time,  4:30 p.m. Eastern Time.

Conference Call Details

Date:Feb. 10, 2025
   
Time:1:30 pm PT / 4:30 pm ET
   
Hosts:Jitendra Mohan, Chief Executive Officer
Sanjay Gajendra, President and Chief Operating Officer
Mike Tate, Chief Financial Officer
   
Dial-in:(800) 715-9871
Conference ID: 5908687
   
Webcast:https://ir.asteralabs.com
 

About Astera Labs
Astera Labs is a global leader in purpose-built connectivity solutions that unlock the full potential of AI and cloud infrastructure. Our Intelligent Connectivity Platform integrates PCIe ®, CXL ®, and Ethernet semiconductor-based solutions and the COSMOS software suite of system management and optimization tools to deliver a software-defined architecture that is both scalable and customizable. Inspired by trusted relationships with hyperscalers and the data center ecosystem, we are an innovation leader delivering products that are flexible and interoperable. Discover how we are transforming modern data-driven applications at  www.asteralabs.com.

© Astera Labs, Inc. Astera Labs, and its stylized logo, are trademarks of Astera Labs, Inc. or its affiliates. Other names and brands may be claimed as the property of others.

Investor Contact:
Leslie Green
Leslie.green@asteralabs.com



Article by:Source- Investing.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

Most Popular

ADVERTISEMENT
To Top